Literature DB >> 9516408

Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro.

S Sato1, C L Ward, R R Kopito.   

Abstract

Ubiquitination is a covalent protein modification that can target proteins in eukaryotic cells for degradation by the 26 S proteasome. Substrates for this degradation pathway include abnormal proteins that arise from misfolding and/or mutation. How and when the ubiquitination machinery recognizes misfolded proteins and targets them for degradation remains largely unknown. We have previously shown that cystic fibrosis transmembrane conductance regulator (CFTR), is rapidly degraded in a ubiquitin-dependent fashion, without any detectable lag following its synthesis (Ward, C. L., and Kopito, R. R. (1994) J. Biol. Chem. 269, 25710-25718), suggesting that ubiquitination and protein synthesis may be temporally linked. In the present study, we have investigated the timing of CFTR ubiquitination relative to its translation in reticulocyte lysates containing 125I-ubiquitin. In synchronized, proteasome-inhibited lysates, translation of full-length CFTR chains was completed in approximately 30 min, whereas modification of CFTR with [125I]ubiquitin was evident by 20 min, indicating that ubiquitination precedes the completion of full-length polypeptide chains. Moreover, ubiquitin was also found to be transferred to nascent CFTR chains while attached to ribosomes. Together, these data establish that ubiquitination, which is widely assumed to be a post-translational event, can occur cotranslationally and suggest a role for ubiquitination early in protein biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516408     DOI: 10.1074/jbc.273.13.7189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage.

Authors:  S Vispe; T M Yung; J Ritchot; H Serizawa; M S Satoh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 2.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 binds the proteasome in the presence of translationally damaged proteins.

Authors:  Show-Mei Chuang; Kiran Madura
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

4.  Side chain and backbone contributions of Phe508 to CFTR folding.

Authors:  Patrick H Thibodeau; Chad A Brautigam; Mischa Machius; Philip J Thomas
Journal:  Nat Struct Mol Biol       Date:  2004-12-26       Impact factor: 15.369

5.  Subcellular distribution of proteasomes implicates a major location of protein degradation in the nuclear envelope-ER network in yeast.

Authors:  C Enenkel; A Lehmann; P M Kloetzel
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

Review 6.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

7.  A cotranslational ubiquitination pathway for quality control of misfolded proteins.

Authors:  Feng Wang; Larissa A Durfee; Jon M Huibregtse
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

8.  Principles of cotranslational ubiquitination and quality control at the ribosome.

Authors:  Stefanie Duttler; Sebastian Pechmann; Judith Frydman
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

Review 9.  Ribosome-based quality control of mRNA and nascent peptides.

Authors:  Carrie L Simms; Erica N Thomas; Hani S Zaher
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-05-18       Impact factor: 9.957

10.  Electrostatics in the ribosomal tunnel modulate chain elongation rates.

Authors:  Jianli Lu; Carol Deutsch
Journal:  J Mol Biol       Date:  2008-09-16       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.